Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported ...
Screen Rant on MSN
Brian Cox’s new R-rated sequel movie continues disappointing 25-year Rotten Tomatoes streak
Brian Cox's cult classic R-rated franchise is back with a new sequel, which is continuing a disappointing Rotten Tomatoes ...
Sports Mole previews Thursday's Europa League qualifier between PAOK and Anderlecht, including predictions, team news and ...
Company reports preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million and gross margin of approximately 35% year-to-date FY 2026 sales guidance increased to $140 - $150 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results